Joseph EdelmanIKT history

Issuer:
INHIBIKASE THERAPEUTICS INC
Quarters tracked:
6 (Q4 2024Q1 2026)
Current shares:
2,315,000
Current value:
$3.89M
Peak shares:
5,925,000 (Q4 2024)
Overall change:
-61%
QuarterSharesValue$/ShareShare ΔΔ%
Q1 20262,315,000$3.89M$1.68-3,106,568-57%
Q4 20255,421,568$11.11M$2.0500%
Q3 20255,421,568$8.78M$1.62-10,7250%
Q2 20255,432,293$10.59M$1.95-492,707-8%
Q1 20255,925,000$12.98M$2.1900%
Q4 20245,925,000$19.26M$3.25NEW